BCP Partnering Portal / AmoyDx
AmoyDx - Manufacturer based in Fujian, China
AmoyDx is a Chinese biotechnology company that specializes in molecular diagnostics for cancer treatment. The company develops and provides a range of diagnostic products and services, including immunohistochemistry, polymerase chain reaction, next-generation sequencing, fluorescence in situ hybridization, and nucleic acid extraction products, as well as detection services and instrument and equipment. These products are designed to help detect and diagnose cancer, and some have been approved by regulatory authorities such as the National Medical Products Administration and the European Union's ISO13485. AmoyDx's products and services aim to support personalized cancer treatment by providing accurate and reliable diagnostic results.
About AmoyDx
We produce the real-time PCR assays to detect gene mutations and measure gene expression in FFPE cancer tissue and body fluids, which are manufactured in an ISO13485-certified, GMP compliant facility.
The nine products - EGFR, KRAS 7, BRAF, PIK3CA, EML4-ALK, ROS1, RET, ALK/ROS1, ERCC1 - are CE marked for IVD use in Europe.
The KRAS 19 and NRAS 16 kits will be CE marked soon.
We partner with global pharmaceutical companies, such as AstraZeneca, Pfizer…
Looking for Channel Partners in:
Product Types:
Industries:
Products, Services & Applications:

Where Manufacturers and Channel Partners / Distributors find each other!